Condition

Hypertensive Disease

ClinicalTrials.gov condition label

Clinical trials14
Recruiting0
Common interventions21
Lead sponsors shown14

Clinical trials

14 shown
A Health Coach-Led Digital Lifestyle Intervention (HEALDI)NCT07530562 · 2026-04-01
NOT_YET_RECRUITING
SMART-IC-Pilot StudyNCT07336433 · 2026-01-01
NOT_YET_RECRUITING
Implications of Maternal 45,X Mosaicism as a Secondary Genomic Finding Following Cell-Free DNA Sequencing During Pregnancy: A Deep Phenotype StudyNCT05548881 · 2025-04-01
WITHDRAWN
Evaluation of Transcranial Doppler Vasoconstrictor Vasoreactivity During General Anesthesia in Hypertensive PatientsNCT03897790 · 2019-04-02
WITHDRAWN
Retention of Potassium From Potatoes and Potassium Gluconate, and the Effect on Blood Pressure.NCT02697708 · 2016-04-27
UNKNOWN
Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose CombinationNCT02655029 · 2015-11-25
COMPLETED
To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot StudyNCT02299388 · 2014-10-01
COMPLETED
Vascular Lifestyle-Intervention and Screening in PharmacyNCT02223793 · 2014-09-01
UNKNOWN
Acupuncture as a Complementary Treatment for Hypertension (ACT-HAS)NCT02530853 · 2014-08-01
UNKNOWN
Medication Adherence and "True" Resistance in Patients With Resistant HypertensionNCT02128386 · 2014-02-01
UNKNOWN
Activating Media for Salt ReductionNCT03074851 · 2012-12-01
COMPLETED
Effect of Vitamin D3 on Cardiovascular Risk FactorsNCT01501916 · 2012-12-01
COMPLETED
Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With NormoalbuminuriaNCT01500590 · 2011-11-01
UNKNOWN
Effect of Acute Arterial Hypertension on Morphine's Requirements and Postsurgical Pain.NCT01897155 · 2010-01-01
COMPLETED

Common interventions

French Fries DietDIETARY_SUPPLEMENT1HEALDI InterventionOTHER1Information on high risk factor levels and lifestyle adviceBEHAVIORAL1informational interventionOTHER1Laser acupunctureOTHER1Liraglutide or PlaceboDRUG1low sodium saltDIETARY_SUPPLEMENT1No information on high risk factor levels but lifestyle adviceBEHAVIORAL1No information on high risk factor levels, nor lifestyle adviceBEHAVIORAL1non-renin angiotensin system blockersDRUG1Perindopril/Indapamide/Amlodipine fixed dose combinationDRUG1PlaceboDIETARY_SUPPLEMENT1Potassium control dietDIETARY_SUPPLEMENT1Potassium gluconate dietDIETARY_SUPPLEMENT1Potato DietDIETARY_SUPPLEMENT1Renin-angiotensin system blockersDRUG1SBP 20-30% over baselineOTHER1SBP 20-30% under baselineOTHER1The SymPioneer G2 Mapping/Selective Renal Denervation Device and SyMapCath Catheter IIDEVICE1Transcranial Doppler (DTC)OTHER1Vitamin D3DIETARY_SUPPLEMENT1

Leading sponsors

Charite University, Berlin, Germany1Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1Hospital Authority, Hong Kong1Martin-Luther-Universität Halle-Wittenberg1National University of Singapore1Pontificia Universidad Catolica de Chile1Purdue University1Servier Hellas Pharmaceuticals Ltd.1SyMap Medical (Suzhou), Ltd.1The George Institute for Global Health, China1Tulane University School of Medicine1Universidade Federal do Rio de Janeiro1University Hospital, Tours1University of Oslo1

Trial status mix

COMPLETED5
UNKNOWN5
NOT_YET_RECRUITING2
WITHDRAWN2

Phase mix

NA6
PHASE43
PHASE11
PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.